Effects of Narrative Writing Duration and Post-writing Processing Instructions on PTSD
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01773811|
Recruitment Status : Completed
First Posted : January 23, 2013
Last Update Posted : May 15, 2014
|Condition or disease||Intervention/treatment||Phase|
|Posttraumatic Stress Disorder (PTSD)||Behavioral: Narrative Writing: Trauma-Assigned Behavioral: Narrative Writing: Trauma-Spontaneous||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||49 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effects of Narrative Writing Duration and Post-writing Processing Instructions on PTSD|
|Study Start Date :||February 2012|
|Actual Primary Completion Date :||May 2014|
|Actual Study Completion Date :||May 2014|
No Intervention: Control
Individuals will write objectively about the events of their day.
Experimental: Narrative Writing: Trauma-Assigned
Trauma-assigned: Individuals will write about their most traumatic life experience and be instructed to continue to think about their writing topic in the weeks following writing.
Behavioral: Narrative Writing: Trauma-Assigned
Individuals will be writing about their most traumatic life event for 3 consecutive days for 20 minutes each. Those in the assigned group will be given instructions and weekly reminders to continue to think about their most traumatic event.
Active Comparator: Narrative Writing: Trauma-Spontaneous
Individuals will write about their most traumatic life experience but will not be given further instructions for processing. Any additional processing about their writing topic in the weeks following writing will be considered spontaneous.
Behavioral: Narrative Writing: Trauma-Spontaneous
Individuals will be writing about their most traumatic life event for 3 consecutive days for 20 minutes each. Those in the spontaneous group will be given no further instructions.
- Level of PTSD symptoms as measured by the Clinician Administered PTSD Scale [ Time Frame: 1 month after final writing session ]
- Physical health [ Time Frame: 1 month after final writing session ]Physical health as measured by the Pennebaker Inventory of Limibic Languidness (PILL)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01773811
|United States, Mississippi|
|The University of Mississippi|
|University, Mississippi, United States, 38677|
|Principal Investigator:||Tom Lombardo, PhD||University of Mississippi, Oxford|